Consumers

Line Art 1
Line Art 2
Line Art 3
Line Art 4

Prescryptive Health Announces New Language Capabilities to Increase Patient Accessibility

As part of a multi-language strategy to make healthcare work for everyone, Prescryptive Health launches Spanish language access…

Prescryptive Health Announces New Language Capabilities to Increase Patient Accessibility

The company’s prescription shopping and management experience, myPrescryptive, is now available in Spanish, making it easier for more…

Prescryptive Health anuncia nuevas capacidades de idiomas para aumentar la accesibilidad del paciente

La experiencia de compra y gestión de recetas de la empresa, myPrescryptive, ya está disponible en español, lo…

FTC action on PBMs could be just what the doctor ordered to improve patient outcomes

The FTC’s investigation into the business practices of PBMs could expose the outsized influence PBMs have on access…

As Seen In: HIT Consultant

Prescryptive Health Taps Lilly on First-to-Market Value-Based Program to Stabilize Insulin Pricing

Prescryptive Health partnered with Eli Lilly and Company on a new subscription model to help lower costs for…

As Seen In: Formulary Watch

Prescryptive Health Partners with Lilly for Insulin Program

Prescryptive Health has partnered with Eli Lilly to create a subscription-based insulin program for employers that aims to…

Prescryptive Health Partners with Lilly on First-to-Market Value-Based Program to Stabilize Insulin Pricing

The new financial model aims to provide price transparency while encouraging medication adherence.

As Seen In: Healthcare Americana

PODCAST: Prescryptive’s Chris Blackley on Prescription Drug Market Transparency

Prescryptive CEO, Chris Blackley, joins the Healthcare Americana podcast to discuss the root of the prescription drug pricing…

As Seen In: MedCity News

Pharmacy benefit managers inflate drug prices and decrease competition while consumers pay the price. Does the FTC have the medicine to fix it?

Our CEO Chris Blackley writes in MedCity News about the FTC’s new probe into the big pharmacy benefit…

As Seen In: Forbes

Drug Price Transparency Stymies Consumers, New Survey Shows

As Deb Gordon writes in Forbes about our Pharmacy Trends survey, “…90% of survey respondents said they would appreciate…

As Seen In: BenefitsPRO

3 reasons why owning your pharmacy benefits data matters

Owning your pharmacy benefits data is a must. In her latest Benefits PRO article, Andrea Pickett, Prescryptive’s Chief…